Ambaic, Jericka .

HRN: 20-17-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2023
CEFUROXIME 750MG (VIAL)
07/08/2023
07/14/2023
IVT
750mg
Q8hrs
UTI, URTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: